Moreover, IID activates downstream proinflammatory factors such as IL-6 and TNF-α, which are mainly regulated by NFκB-activated endotoxemia by upregulating the levels of IL-6 and TNF-α, inducing intestinal mucosal injury and chronic inflammatory bowel disease (60). Here, NFKB1 is linked to serum lipopolysaccharide activity.